• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多囊卵巢综合征的最新进展:诊断、遗传病因学和新兴治疗选择的现有知识综述。

An update on polycystic ovary syndrome: A review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options.

机构信息

Biotechnology Program, Department of Mathematics and Natural Sciences, School of Data and Sciences, Brac University, Dhaka, Bangladesh.

Microbiology Program, Department of Mathematics and Natural Sciences, School of Data and Sciences, Brac University, Dhaka, Bangladesh.

出版信息

Womens Health (Lond). 2022 Jan-Dec;18:17455057221117966. doi: 10.1177/17455057221117966.

DOI:10.1177/17455057221117966
PMID:35972046
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9386861/
Abstract

Polycystic ovary syndrome is the most common endocrine disorder in women of reproductive age, which is still incurable. However, the symptoms can be successfully managed with proper medication and lifestyle interventions. Despite its prevalence, little is known about its etiology. In this review article, the up-to-date diagnostic features and parameters recommended on the grounds of evidence-based data and different guidelines are explored. The ambiguity and insufficiency of data when diagnosing adolescent women have been put under special focus. We look at some of the most recent research done to establish relationships between different gene polymorphisms with polycystic ovary syndrome in various populations along with the underestimated impact of environmental factors like endocrine-disrupting chemicals on the reproductive health of these women. Furthermore, the article concludes with existing treatments options and the scopes for advancement in the near future. Various therapies have been considered as potential treatment through multiple randomized controlled studies, and clinical trials conducted over the years are described in this article. Standard therapies ranging from metformin to newly found alternatives based on vitamin D and gut microbiota could shine some light and guidance toward a permanent cure for this female reproductive health issue in the future.

摘要

多囊卵巢综合征是育龄妇女中最常见的内分泌紊乱疾病,目前仍无法治愈。然而,通过适当的药物治疗和生活方式干预,可以成功地控制其症状。尽管其发病率很高,但人们对其病因知之甚少。在这篇综述文章中,我们探讨了基于循证数据和不同指南推荐的最新诊断特征和参数。特别关注了在诊断青春期女性时数据的模糊性和不足。我们研究了一些最近的研究,以确定不同人群中多囊卵巢综合征与不同基因多态性之间的关系,以及环境因素(如内分泌干扰化学物质)对这些女性生殖健康的被低估的影响。此外,本文还总结了现有的治疗选择和未来的发展前景。通过多项随机对照研究,已经考虑了多种治疗方法,本文描述了多年来进行的临床试验。从二甲双胍到基于维生素 D 和肠道微生物群的新发现的替代方法,各种标准疗法都被认为是潜在的治疗方法,这为未来针对这种女性生殖健康问题的永久性治疗提供了一些启示和指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089b/9386861/0ac510006c01/10.1177_17455057221117966-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089b/9386861/b44a705ca918/10.1177_17455057221117966-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089b/9386861/3839a11aee7e/10.1177_17455057221117966-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089b/9386861/4a8a74920ded/10.1177_17455057221117966-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089b/9386861/0ac510006c01/10.1177_17455057221117966-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089b/9386861/b44a705ca918/10.1177_17455057221117966-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089b/9386861/3839a11aee7e/10.1177_17455057221117966-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089b/9386861/4a8a74920ded/10.1177_17455057221117966-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089b/9386861/0ac510006c01/10.1177_17455057221117966-fig4.jpg

相似文献

1
An update on polycystic ovary syndrome: A review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options.多囊卵巢综合征的最新进展:诊断、遗传病因学和新兴治疗选择的现有知识综述。
Womens Health (Lond). 2022 Jan-Dec;18:17455057221117966. doi: 10.1177/17455057221117966.
2
The role of metformin in the management of polycystic ovary syndrome.二甲双胍在多囊卵巢综合征管理中的作用。
Curr Opin Obstet Gynecol. 2003 Dec;15(6):483-8. doi: 10.1097/00001703-200312000-00005.
3
Polycystic ovary syndrome update in adolescence.青少年多囊卵巢综合征的最新进展
Curr Opin Pediatr. 2007 Aug;19(4):389-97. doi: 10.1097/MOP.0b013e328236743f.
4
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.美国临床内分泌医师协会、美国内分泌学会以及雄激素过多与多囊卵巢综合征协会疾病状态临床综述:多囊卵巢综合征评估与治疗最佳实践指南——第1部分。
Endocr Pract. 2015 Nov;21(11):1291-300. doi: 10.4158/EP15748.DSC.
5
Is pharmacogenomics our future? Metformin, ovulation and polymorphism of the STK11 gene in polycystic ovary syndrome.药物基因组学是我们的未来吗?二甲双胍、排卵与多囊卵巢综合征中STK11基因的多态性。
Pharmacogenomics. 2008 Aug;9(8):1163-5. doi: 10.2217/14622416.9.8.1163.
6
Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.二甲双胍联合生活方式改变治疗多囊卵巢综合征的系统评价和荟萃分析。
Hum Reprod Update. 2015 Sep-Oct;21(5):560-74. doi: 10.1093/humupd/dmv025. Epub 2015 Jun 9.
7
Metformin and polycystic ovary syndrome.二甲双胍与多囊卵巢综合征
Curr Opin Endocrinol Diabetes Obes. 2007 Apr;14(2):132-40. doi: 10.1097/MED.0b013e328089f0ea.
8
[Advance in treatment of polycystic ovary syndrome].[多囊卵巢综合征的治疗进展]
Pol Merkur Lekarski. 2005 Dec;19(114):848-54.
9
Update on the management of polycystic ovary syndrome.多囊卵巢综合征管理的最新进展。
Pharmacol Rep. 2006 Sep-Oct;58(5):614-25.
10
Homocysteine levels are unaffected by metformin treatment in both nonpregnant and pregnant women with polycystic ovary syndrome.在患有多囊卵巢综合征的非孕妇和孕妇中,同型半胱氨酸水平不受二甲双胍治疗的影响。
Acta Obstet Gynecol Scand. 2007;86(2):145-50. doi: 10.1080/00016340600855946.

引用本文的文献

1
A Pilot Study of the Role of Salivary Biomarkers in the Diagnosis of PCOS in Adolescents Across Different Body Weight Categories.唾液生物标志物在不同体重类别的青少年多囊卵巢综合征诊断中作用的初步研究。
J Clin Med. 2025 Aug 31;14(17):6159. doi: 10.3390/jcm14176159.
2
Multi-specialty Physician Preferences and Perceptions in Treatment and Management of Polycystic Ovary Syndrome in China: Survey and Discrete Choice Experiment.中国多专科医生对多囊卵巢综合征治疗与管理的偏好和认知:调查与离散选择实验
Adv Ther. 2025 Aug 8. doi: 10.1007/s12325-025-03311-7.
3
Combination of Diane-35 and Cangfu Daotan Wan Effectively Ameliorates Inflammatory Response, Stress State, and Hormone Levels in Patients with Polycystic Ovary Syndrome (PCOS), Leading to Significant Improvement in Clinical Treatment Outcomes.

本文引用的文献

1
Investigation of the , and Mutations and Polymorphisms in Iranian Infertile Women with Polycystic Ovary Syndrome (PCOS).对患有多囊卵巢综合征(PCOS)的伊朗不孕女性中 、 和 突变及多态性的研究。 (注:原文中“Investigation of the, and ”部分内容缺失,请补充完整以便准确翻译)
Rep Biochem Mol Biol. 2021 Jan;9(4):470-477. doi: 10.52547/rbmb.9.4.470.
2
Variation analysis of anti-Müllerian hormone gene in Chinese women with polycystic ovary syndrome.多囊卵巢综合征中国女性抗苗勒管激素基因变异分析。
Endocrine. 2021 Apr;72(1):287-293. doi: 10.1007/s12020-020-02538-4. Epub 2020 Nov 9.
3
Sitagliptin/Metformin: A New Medical Treatment in Polycystic Ovary Syndrome.
达英-35与苍附导痰丸联合使用可有效改善多囊卵巢综合征(PCOS)患者的炎症反应、应激状态和激素水平,显著提高临床治疗效果。
Int J Womens Health. 2025 Jul 29;17:2353-2364. doi: 10.2147/IJWH.S526092. eCollection 2025.
4
Immunoendocrine Insights Into Dehydroepiandrosterone by Cytokine Profiling in Sub-fertile Women Undergoing Intrauterine Insemination.通过对接受宫内人工授精的不孕女性进行细胞因子分析对脱氢表雄酮的免疫内分泌学见解
Cureus. 2025 Jun 28;17(6):e86899. doi: 10.7759/cureus.86899. eCollection 2025 Jun.
5
The relationship between polycystic ovary syndrome and gynecological cancers: neurotransmitter metabolism changes and immune regulation.多囊卵巢综合征与妇科癌症之间的关系:神经递质代谢变化与免疫调节
Front Immunol. 2025 Jun 4;16:1578470. doi: 10.3389/fimmu.2025.1578470. eCollection 2025.
6
Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation.内分泌、代谢及炎症方面的多囊卵巢综合征病理生理学
J Ovarian Res. 2025 Feb 20;18(1):34. doi: 10.1186/s13048-025-01621-6.
7
A Systematic Review of Spironolactone Nano-Formulations for Topical Treatment of Skin Hyperandrogenic Disorders and Chronic Wounds.螺内酯纳米制剂用于局部治疗皮肤高雄激素性疾病和慢性伤口的系统评价
Pharmaceutics. 2024 Dec 27;17(1):27. doi: 10.3390/pharmaceutics17010027.
8
Polycystic ovary syndrome negatively affects sexual function and lower urinary tract symptoms in syrian women: a case-control study.多囊卵巢综合征对叙利亚女性的性功能和下尿路症状有负面影响:一项病例对照研究。
Sci Rep. 2025 Jan 6;15(1):987. doi: 10.1038/s41598-025-85544-8.
9
Assessment of the Validity and Quality of Polycystic Ovarian Syndrome (PCOS) Screening Tools Available for Women Globally: A Systematic Review.全球女性多囊卵巢综合征(PCOS)筛查工具的有效性和质量评估:一项系统综述
Clin Pract. 2024 Aug 23;14(5):1625-1649. doi: 10.3390/clinpract14050131.
10
Plant medicine metabolite Yulinzhu treating neurological disorder causing polycystic ovary syndrome: a systematic review and a meta-analysis.植物药代谢物玉林珠治疗导致多囊卵巢综合征的神经紊乱:一项系统评价和荟萃分析。
Front Pharmacol. 2024 Aug 15;15:1458621. doi: 10.3389/fphar.2024.1458621. eCollection 2024.
西格列汀/二甲双胍:多囊卵巢综合征的新医学疗法。
Trends Endocrinol Metab. 2020 Dec;31(12):890-892. doi: 10.1016/j.tem.2020.09.002. Epub 2020 Oct 12.
4
Association of the and gene polymorphisms in women with polycystic ovary syndrome from Punjab, Pakistan.巴基斯坦旁遮普地区多囊卵巢综合征女性中 和 基因多态性的相关性。
Gynecol Endocrinol. 2021 May;37(5):456-461. doi: 10.1080/09513590.2020.1822803. Epub 2020 Sep 22.
5
Polycystic ovarian syndrome in adolescents: From diagnostic criteria to therapeutic management.青少年多囊卵巢综合征:从诊断标准到治疗管理
Acta Biomed. 2020 Sep 7;91(3):e2020085. doi: 10.23750/abm.v91i3.10162.
6
PCOSKB: a database of genes, diseases, pathways, and networks associated with polycystic ovary syndrome.多囊卵巢综合征相关基因、疾病、通路和网络数据库(PCOSKB)。
Sci Rep. 2020 Sep 7;10(1):14738. doi: 10.1038/s41598-020-71418-8.
7
Association of Metformin With Pregnancy Outcomes in Women With Polycystic Ovarian Syndrome Undergoing In Vitro Fertilization: A Systematic Review and Meta-analysis.二甲双胍与接受体外受精的多囊卵巢综合征妇女妊娠结局的关系:系统评价和荟萃分析。
JAMA Netw Open. 2020 Aug 3;3(8):e2011995. doi: 10.1001/jamanetworkopen.2020.11995.
8
A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome.多囊卵巢综合征代谢方面管理的治疗选择综述。
Ther Adv Endocrinol Metab. 2020 Jul 6;11:2042018820938305. doi: 10.1177/2042018820938305. eCollection 2020.
9
Controversies in the diagnosis of polycystic ovary syndrome.多囊卵巢综合征诊断中的争议
Ther Adv Reprod Health. 2020 Jun 29;14:2633494120913032. doi: 10.1177/2633494120913032. eCollection 2020 Jan-Dec.
10
Association of the Genetic Polymorphisms rs6259 and rs727428 of the Gene with Polycystic Ovary Syndrome Risk: A Meta-Analysis.基因 rs6259 和 rs727428 的遗传多态性与多囊卵巢综合征风险的关联:一项荟萃分析。
Genet Test Mol Biomarkers. 2020 Aug;24(8):492-501. doi: 10.1089/gtmb.2019.0229. Epub 2020 Jun 24.